Boston Scientific's device shows promise in restoring normal heart rhythms

09/3/2013 | MassDevice.com (Boston)

A study of 330 patients implanted with Boston Scientific's subcutaneous implantable cardiac defibrillator found that the device successfully restored normal heart rhythms in 38 patients who suffered heart irregularity during an 11-month evaluation period. The device also reversed heart rhythm irregularity 100% of the time, surpassing the FDA target of an 88% response rate, when researchers tested it by causing an abnormal heart rhythm, according to the study in the journal Circulation.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC